X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (39) 39
humans (37) 37
dermatology (32) 32
vitiligo (27) 27
male (18) 18
adult (16) 16
female (16) 16
melanoma (13) 13
middle aged (13) 13
vitiligo - pathology (12) 12
oncology (11) 11
skin (11) 11
cell biology (9) 9
pathogenesis (7) 7
vitiligo - therapy (7) 7
skin diseases (6) 6
vitiligo - diagnosis (6) 6
vitiligo - immunology (6) 6
generalized vitiligo (5) 5
integumentary system (5) 5
medicine and health sciences (5) 5
melanocyte (5) 5
melanoma - immunology (5) 5
regulatory t-cells (5) 5
severity of illness index (5) 5
susceptibility loci (5) 5
t-cells (5) 5
vitiligo - genetics (5) 5
analysis (4) 4
animals (4) 4
article (4) 4
clinical trials (4) 4
dendritic cells (4) 4
diagnosis (4) 4
expression (4) 4
immunosuppressive agents - therapeutic use (4) 4
indoleamine 2,3-dioxygenase (4) 4
medical colleges (4) 4
prognosis (4) 4
psoriasis (4) 4
segmental vitiligo (4) 4
skin neoplasms - immunology (4) 4
skin neoplasms - pathology (4) 4
skin pigmentation (4) 4
t cells (4) 4
treatment outcome (4) 4
young adult (4) 4
age (3) 3
biomarkers - blood (3) 3
body surface area (3) 3
cancer (3) 3
care and treatment (3) 3
cd8-positive t-lymphocytes - immunology (3) 3
cells (3) 3
cosmin (3) 3
disease progression (3) 3
disease-activity (3) 3
double-blind (3) 3
flow cytometry (3) 3
genetic aspects (3) 3
halo nevi (3) 3
human melanocytes (3) 3
immune response (3) 3
immunology (3) 3
inflammation (3) 3
lymphocytes (3) 3
melanoma - pathology (3) 3
observer variation (3) 3
oxidative stress (3) 3
prospective studies (3) 3
proteins (3) 3
quality-of-life (3) 3
repigmentation (3) 3
research (3) 3
review (3) 3
risk factors (3) 3
sensitivity and specificity (3) 3
severity (3) 3
skin - pathology (3) 3
surgery (3) 3
surgical treatment (3) 3
usage (3) 3
vitiligo - blood (3) 3
vitiligo - drug therapy (3) 3
vitiligo - metabolism (3) 3
abridged index medicus (2) 2
administration, cutaneous (2) 2
adolescent (2) 2
aged (2) 2
alopecia-areata (2) 2
area (2) 2
association (2) 2
autoimmune diseases (2) 2
autoimmune vitiligo (2) 2
autoimmune-diseases (2) 2
biochemistry, genetics and molecular biology (2) 2
biologics (2) 2
biopsy (2) 2
case-control studies (2) 2
classification (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Pigment Cell & Melanoma Research, ISSN 1755-1471, 11/2019, Volume 32, Issue 6, pp. 842 - 847
Multiple reports confirm elevated circulating IL‐17 levels and increased numbers of Th17 lymphocytes in patients with non‐segmental vitiligo. Additionally,... 
vitiligo | IL‐17 | Th17 pathway | Vitiligo | Cytokines | Lymphocytes | Medical treatment | Helper cells | Skin | Lymphocytes T | Cell differentiation | Chemokines
Journal Article
Nature communications, ISSN 2041-1723, 2019, Volume 10, Issue 1, pp. 391 - 10
Vitiligo is an autoimmune disease in which melanocyte destruction causes skin depigmentation, with 49 loci known from previous GWAS. Aiming to define vitiligo... 
DISEASES | MULTIDISCIPLINARY SCIENCES | SUSCEPTIBILITY LOCI | DNA ELEMENTS | RISK | PREVALENCE | GENOME-WIDE ASSOCIATION | Haplotypes | Dendritic cells | Health risks | mRNA | Gene expression | Loci | Subgroups | Proteins | Monocytes | Vitiligo | Enhancers | Major histocompatibility complex | Histocompatibility antigen HLA | Variation | Autoimmune diseases | Age
Journal Article
FRONTIERS IN IMMUNOLOGY, ISSN 1664-3224, 08/2019, Volume 10, p. 1918
The impressive potential of biologics has been demonstrated in psoriasis, hidradenitis suppurativa, and urticaria. Numerous biologicals are entering the field... 
CD20 | biologics | TNF-alpha | IL-1 | IgE | SWEET SYNDROME | LUPUS-ERYTHEMATOSUS | IMMUNOLOGY | IL-12 | IL-23 | RECEPTOR ANTAGONIST | IGE AUTOANTIBODIES | ALOPECIA-AREATA | PYODERMA-GANGRENOSUM | DOUBLE-BLIND | CASE SERIES | HIDRADENITIS SUPPURATIVA | off-label | Omalizumab | Skin diseases | Usage | Care and treatment | Biological products | Risk factors | Psoriasis | Drug therapy | TNF-α
Journal Article
Nature Communications, ISSN 2041-1723, 2019, Volume 10, Issue 1
Vitiligo is an autoimmune disease in which melanocyte destruction causes skin depigmentation, with 49 loci known from previous GWAS. Aiming to define vitiligo... 
Journal Article
04/2018, ISBN 9781118937419, 536
eBook
Journal of the American Academy of Dermatology, ISSN 0190-9622, 05/2018, Volume 78, Issue 5, pp. 1013 - 1015
Journal Article
Journal of Investigative Dermatology, ISSN 0022-202X, 01/2016, Volume 136, Issue 1, pp. 6 - 7
The impact of vitiligo is generally believed to be underestimated. Salzes et al. propose a questionnaire to measure the actual burden of vitiligo. Using a... 
Sickness Impact Profile | Vitiligo - psychology | Humans | Female | Male | Surveys and Questionnaires | Quality of Life - psychology | INSTRUMENT | PSORIASIS | DERMATOLOGY
Journal Article
American Journal of Clinical Dermatology, ISSN 1175-0561, 10/2018, Volume 19, Issue 5, pp. 625 - 637
New promising treatments have been developed for psoriasis that target different parts of the interleukin (IL)-23/IL-17 pathway. This approach is believed to... 
CONTROLLED-TRIAL | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | TUMOR-NECROSIS-FACTOR | DUAL INHIBITION | IFN-GAMMA | SEVERE PLAQUE PSORIASIS | ARTHRITIS PATIENTS | HOST-DEFENSE | EPIDERMAL HYPERPLASIA | T-CELLS | DERMATOLOGY
Journal Article
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 03/2017, Volume 76, Issue 3, pp. 464 - 471
Background The Vitiligo Extent Score (VES) has recently been introduced as a physicians' score for the clinical assessment of the extent of vitiligo, but a... 
severity | patient-reported outcomes | Dermatology | outcome measurement | vitiligo | body surface area
Journal Article
American journal of clinical dermatology, 12/2017, Volume 18, Issue 6, p. 733
The pathophysiology of vitiligo is becoming increasingly clarified. In non-segmental vitiligo, early factors include activation of innate immunity,... 
Lasers, Excimer | Vitiligo - therapy | Photosensitizing Agents - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Skin Pigmentation | Combined Modality Therapy | Plant Extracts - therapeutic use | Vitiligo - physiopathology | Phototherapy
Journal Article
Journal Article
Pigment Cell and Melanoma Research, ISSN 1755-1471, 2019, Volume 32, Issue 5, pp. 728 - 733
Currently, vitiligo lacks a validated Physician Global Assessment (PGA) for disease extent. This PGA can be used to stratify and interpret the numeric scores... 
Journal Article
American Journal of Clinical Dermatology, ISSN 1175-0561, 12/2017, Volume 18, Issue 6, pp. 733 - 744
The pathophysiology of vitiligo is becoming increasingly clarified. In non-segmental vitiligo, early factors include activation of innate immunity,... 
NARROW-BAND-UVB | GENERALIZED VITILIGO | DOUBLE-BLIND | SUSCEPTIBILITY LOCI | TERM-FOLLOW-UP | TOPICAL TACROLIMUS | TACROLIMUS OINTMENT | NON-SEGMENTAL VITILIGO | DISEASE-ACTIVITY | B PHOTOTHERAPY | DERMATOLOGY
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.